- Report
- March 2024
- 196 Pages
Global
From €3229EUR$3,374USD£2,744GBP
€3588EUR$3,749USD£3,049GBP
- Report
- January 2024
- 200 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- February 2024
- 250 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- May 2024
- 140 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- April 2024
- 137 Pages
Global
From €3732EUR$3,899USD£3,171GBP
- Report
- June 2024
- 93 Pages
Global
From €5360EUR$5,600USD£4,554GBP
- Report
- February 2024
- 125 Pages
Global
From €4546EUR$4,750USD£3,863GBP
- Report
- August 2023
- 255 Pages
Global
From €9092EUR$9,500USD£7,725GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1436EUR$1,500USD£1,220GBP
- Report
- May 2024
- 128 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 138 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 138 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 137 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 140 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- February 2024
- 117 Pages
Global
From €4546EUR$4,750USD£3,863GBP
- Report
- November 2023
- 180 Pages
Global
From €4690EUR$4,900USD£3,985GBP
- Report
- May 2024
- 200 Pages
Global
From €3972EUR$4,150USD£3,375GBP
- Report
- April 2024
- 80 Pages
United States
From €2484EUR$2,595USD£2,110GBP
- Report
- April 2024
- 100 Pages
Africa
From €3632EUR$3,795USD£3,086GBP
- Report
- January 2022
- 148 Pages
Global
From €4068EUR$4,250USD£3,456GBP
Memantine is a drug used to treat symptoms of Alzheimer's disease and other forms of dementia. It is classified as an NMDA receptor antagonist, which works by blocking the action of a neurotransmitter called glutamate. This helps to reduce the symptoms of dementia, such as memory loss, confusion, and difficulty with language. Memantine is also used to treat Parkinson's disease, Huntington's disease, and multiple sclerosis.
Memantine is a relatively new drug, having been approved by the FDA in 2003. It is available in both oral and intravenous forms, and is typically prescribed in combination with other drugs. It is generally well-tolerated, with few side effects.
The memantine market is a growing one, with a number of companies offering products. These include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Other companies, such as Actavis, Lupin, and Dr. Reddy's Laboratories, also offer generic versions of the drug. Show Less Read more